The Basics of Biopharmaceuticals and Biosimilars course provides foundational knowledge of biologic medicines and their biosimilar counterparts used in modern healthcare. It focuses on understanding how these complex therapies are developed, regulated, and applied in clinical practice. This course supports Terraleap’s mission to deliver up-to-date, industry-relevant education for healthcare and life-science learners.

This course covers core concepts of biopharmaceuticals, including biologic drug classification, manufacturing principles, mechanisms of action, and therapeutic applications. It also introduces biosimilars, highlighting comparability, regulatory pathways, safety, efficacy, and pharmacovigilance considerations.

By the end of this course, learners will be able to:

• Understand the fundamentals of biopharmaceuticals and biosimilars

• Differentiate between biologics, biosimilars, and conventional drugs

• Explain basic development and regulatory principles

• Recognize clinical and safety considerations of biologic therapies

• Appreciate the role of biosimilars in healthcare systems

After completing the course, learners will be able to:

• Demonstrate foundational knowledge of biologic medicines

• Understand the clinical relevance of biosimilars

• Support informed use of biopharmaceuticals in healthcare settings

• Communicate basic concepts related to biologics and biosimilars

• Apply knowledge in academic, clinical, or industry contexts

This course is suitable for:

• Pharmacists and pharmacy technicians

• Medical, nursing, and allied health professionals

• Life sciences and biotechnology students

• MedTech and healthcare industry professionals

• Individuals seeking introductory knowledge in biopharmaceuticals